|

PRG-1801 （CAR-T against BCMA） Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Lingli Dong1

Indications

  • ANCA Associated Vasculitis1
  • Lupus Nephritis1
  • Lupus1

Other1 trial

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.